Which route produces a faster onset for epinephrine 1:1000 administration?

Prepare for emergency medicine exams with our comprehensive test. Explore multiple choice questions, receive hints and explanations. Sharpen your knowledge and ensure success!

Multiple Choice

Which route produces a faster onset for epinephrine 1:1000 administration?

Explanation:
Absorption rate by route controls how quickly a drug takes effect. For epinephrine given at 1:1000 for acute allergic reactions, the intramuscular route delivers the drug into well-vascularized muscle, leading to rapid and reliable absorption into the bloodstream. This makes the onset faster than subcutaneous administration, which passes more slowly through fat tissue. Inhalation delivers the drug through the lungs but is slower and more variable for producing a systemic effect. While intravenous administration would be almost instantaneous in general, the 1:1000 concentration is not used IV due to safety concerns; IV epinephrine is typically given in a 1:10,000 dilution when a rapid, controlled effect is needed. Therefore, intramuscular administration provides the quickest onset among these options in this dosing context.

Absorption rate by route controls how quickly a drug takes effect. For epinephrine given at 1:1000 for acute allergic reactions, the intramuscular route delivers the drug into well-vascularized muscle, leading to rapid and reliable absorption into the bloodstream. This makes the onset faster than subcutaneous administration, which passes more slowly through fat tissue. Inhalation delivers the drug through the lungs but is slower and more variable for producing a systemic effect. While intravenous administration would be almost instantaneous in general, the 1:1000 concentration is not used IV due to safety concerns; IV epinephrine is typically given in a 1:10,000 dilution when a rapid, controlled effect is needed. Therefore, intramuscular administration provides the quickest onset among these options in this dosing context.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy